In October 2012 the American Academy of Pediatrics (AAP) report on Evidence-based Child and Adolescent Pyschosocial Interventions concluded that for the Attention and Hyperactivity behavioural ...

I will combine somatic work, EMDR, Nervous system focused mapping, IFS, mindfulness-based, CBT, and compassion focused approaches to get the best results. Are you struggling with anxiety or panic?

I've previously defined AI-based therapy micro-bursts, which is how people tend to use AI for mental health advice. Now, here ...

The approval makes Wegovy the first GLP-1 therapy cleared in India for treating adults with non-cirrhotic MASH and ...

If approved, deucrictibant will be the first oral bradykinin B2 receptor antagonist to treat HAE attacksNDA includes positive data from successful clinical program demonstrating rapid relief and ...

From overcoming classical optical limits to tracking single proteins in real time, super-resolution imaging continues to ...

FDA approved veligrotug-vvze for TED regardless of activity or duration, using a 12-week course of five IV infusions administered every three weeks. Pivotal THRIVE/THRIVE-2 trials met primary and all ...

Patients with no other options are watching an agency turn on its own scientists — and the trust that took a century to build ...

Brain abscesses located deep within the brain can rapidly become life-threatening and are often difficult to treat through conventional surgery.

The U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED).

South Carolina – and Columbia – have taken hits in equality and safety rankings as LGBTQ+ issues remain in the political ...

The U.S. ​Food ‌and Drug ​Administration ​has approved Viridian ⁠Therapeutics' ​drug ​to treat patients ​with ​thyroid eye disease, ‌the ⁠company said on ​Friday.